The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Smith Sean Michael since 2022.
This trader's CIK number is 1914769.
At the time of last reporting, Smith Sean Michael was the Interim CFO, Prin Acct Off of Neoleukin Therapeutics, Inc.. (stock ticker symbol NLTX).
Also see all insider trading activities at Neoleukin Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | NLTX | 0 | $0 | 4,639 | $2,796 | 17,500 | $0 |
| 2022 | NLTX | 0 | $0 | 1,655 | $1,640 | 5,000 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-11 | NLTX | Sale | 1,323 | .62 | 817 |
| 2023-08-10 | NLTX | Option Ex | 5,000 | .00 | 0 |
| 2023-02-02 | NLTX | Sale | 3,316 | .60 | 1,979 |
| 2023-02-01 | NLTX | Option Ex | 12,500 | .00 | 0 |
| 2022-08-10 | NLTX | Option Ex | 5,000 | .00 | 0 |
| 2022-08-10 | NLTX | Sale | 1,655 | .99 | 1,640 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Smith Sean Michael (Interim CFO, Prin Acct Off of Neoleukin Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.